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BACKGROUND: There is evidence supporting the efficacy of 
Graded Activity (GA) in managing clinical attributes of patients 
with Low-Back Pain (LBP) in the general population. However, it 
is unknown whether GA alone is efficacious in managing these 
clinical attributes in patients with concomitant LBP and Type-2 
Diabetes (T2D) or additional daily-monitored walking will 
be required.  
METHODS: A single-blind controlled trial involving 58 patients 
(mean age: 48.3±9.4 years, 64.7% females) with concomitant LBP 
and T2D who received treatment twice weekly for twelve weeks was 
conducted. Participants were randomized into GA or GA with 
daily-monitored-walking (GAMW) groups. Pain Intensity (PI), 
Static Back Extensors Endurance (SBEE), Static Abdominal 
Muscular Endurance (SAME) and Glycaemic Control (GC) were 
assessed using Visual Analogue Scale, Biering-Sorensen test, 
flexor endurance test, and in2itTM device respectively at baseline, 
4th, 8th and 12th week. Data were analysed using repeated-
measures ANOVA and Unpaired t-tests at α = 0.05. 
RESULTS: There were significant differences in PI, SAME and 
SBEE among participants in each of GA and GAMW groups 
respectively (p<0.05). Within-group difference on GC was 
significant for GAMW (6.3±0.9%, 5.7±0.7%) but not GA 
(6.3±0.9%, 6.3±0.9%). There was significant difference (p<0.05) 
between GA and GAMW group participants for SBEE (7.2±0.1 sec, 
7.3±0.1 sec) at week 8 of the study and GC (-0.5±0.2%, -0.6±0.5%) 
at the end of the study. No differences were found between GA and 
GAMW groups for PI and SAME. 
CONCLUSION: Graded activity with daily-monitored-walking 
produced positive effects on GC and yielded a better improvement 
on SAME and SBEE. 
KEYWORDS: Graded activity, daily monitored walking, low back 
pain, type 2 diabetes mellitus.  
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Low back pain (LBP), a serious public health 
menace, is a leading cause of work-related 
disability and undue economic burden (1). The 
consequences of LBP include physical problems 
such as reduced back muscle strength and 
endurance (2). The lifetime prevalence estimates of 
LBP range from 49 to 70% (3). This implies that 
most people will experience LBP during their lives. 
Spontaneous recovery from LBP occurs within 3 
months of onset in about 33.3% individuals (4). 
However, over 65% of these individuals will have 
LBP one year after (4). 
Clinical guidelines support the use of 
exercises that encourage people with chronic LBP 
to assume a physically active role in their recovery 
(5). This may be attributed to the many health 
benefits of physical activity (PA) (6). However, 
LBP patients often report low levels of PA 
believing that pain felt because of movement may 
indicate re-injury (7). An example of an exercise-
based treatment approach that encourages patients 
to be as physically active as possible despite pain is 
the graded activity (GA) (8). Graded activity 
comprises four parts: measurements of functional 
capacity, a work-place visit, back school education 
and an individual, submaximal, gradually increased 
exercise program (9). Further, GA utilizes basic 
psychological constructs of specific behavioural 
quotas and methodical reinforcement to progress a 
patient’s therapeutic exercise and activity (8). 
Studies have shown GA to be a promising 
intervention for chronic LBP (10,11). However, 
these favourable reports of GA found in the general 
population cannot be over-emphasized when 
considering LBP among individuals with Type 2 
Diabetes mellitus (T2DM). 
Although the exact aetiology of heightened 
LBP among patients with T2DM is unclear, there is 
evidence that a cascade of events cause a build-up 
of glycation-derived cross links within the 
collagenous rich tissues in the body. These events 
include glycosylation of proteins, atherosclerosis 
within the blood vessels, damage to vascular 
structures; and accumulation of collagen in the skin 
and periarticular structures (12). These glycation-
derived cross links may impact negatively on the 
normal function of the collagenous tissues in the 
body especially at the low back and consequently 
translate into patients experiencing diabetes-
influenced and/or mediated LBP (13). From the 
foregoing discussion, there is a need to find out 
whether GA is efficacious in the management of 
LBP in patients with underlying T2DM. Further, it 
is important to determine the efficacy of GA with 
an additional intervention (e.g. daily-monitored-
walking targeted at problems of T2DM that 
perpetuate LBP including hyperglycaemia and 
muscle weakness). This study, therefore, aimed to 
investigate the efficacy of GA with and without 
daily-monitored-walking on pain intensity, static 
back flexors and static back extensors muscle 
endurance among patients with concomitant LBP 
and T2DM. 
  
MATERIALS AND METHODS 
 
Design: This study was a single-blind randomized 
clinical trial with repeat measures at baseline and at 
the end of weeks 4, 8 and 12 of intervention. The 
University of Ibadan/University College Hospital 
Health Research and Ethics Committee 
(UI/EC/13/0093) gave ethical approval for this 
study.  
Participants: A total number of 58 patients with 
concomitant chronic non-specific LBP and T2DM 
were recruited from the Medical Outpatient and 
Physiotherapy Departments of the Federal Medical 
Center, Ido-Ekiti, Nigeria, and the University of 
Benin Teaching Hospital, Benin-City, Nigeria. 
Prior to the commencement of baseline testing, 
participants read the study information sheet, asked 
questions about their participation, and following a 
verbal explanation of the study procedures, read 
and signed a consent form. Participants then 
completed general questions regarding personal 
details as well as durations of diagnosis of LBP and 
T2DM. Participants were deemed eligible to take 
part in the study if they had chronic non-specific 
LBP of not less than 3 months with concomitant 
T2DM and understood either English or Yoruba 
language. Participants were excluded from the 
study if they had morbidities beside T2DM (like 
uncontrolled hypertension, stroke, and asthma), 
unstable glycaemic control, additional disabling 
conditions such as severe peripheral neuropathy 
and amputations, red flags suggestive of severe 
spinal pathology or inability to understand the 
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instructions or complete the study assessments. 
Two physiotherapists who were recruited 
as research assistants coordinated recruitment, 
eligibility screening, and assignment of the patients 
into the treatment groups. The research assistants 
were blinded to the interventions received by each 
group. Participants were randomized into one of 
two groups: Graded Activity Group (GAG) and 
Graded Activity with-daily-monitored-walking 
(GAMW) Group. 
Interventions: Both groups received GA, while 
participants in the GAMW Group (GAMWG) 
received an additional pedometer-driven daily- 
monitored-walking as PA intervention. Only the 
first author carried out the interventions. The GA 
intervention followed the program described by 
Lindstrom et al. (8,9) based on individual sessions 
of progressive and sub-maximal exercises aimed at 
improving physical fitness and stimulate changes in 
behaviour and patients’ attitudes to pain. The 1-
hour GA program comprised aerobic exercises on 
an elliptical cycle, abdominal sit-up exercises, 
dynamic back extension exercises, bent over row 
dumbbell exercises, and squatting exercises. The 
researcher reviewed exercise targets for each 
participant at the end of each week by determining 
the maximum functional capacity of each patient. 
The patient performed the abdominal situp, 
dynamic back extension, and squatting exercises to 
near fatigue. The researcher then noted the number 
of times the participant could perform the exercise. 
Thereafter, 60% of this number was documented as 
the exercise quota for the week. New exercise 
quotas for the participants were determined weekly 
through the same procedure. The 1-repetitive 
maximum (RM) test was used to determine the 
load of strengthening exercises. During the first 
week of training, individuals exercised using 60% 
of their maximum load. New 1-RM was 
determined weekly for participants. The target 
heart rate of each participant was calculated using 
the Karvonen’s formula. 
In addition, patients were individually 
taught the main content of the Nigerian Back 
School which contained important information on 
the basic anatomy, functions of the muscles, 
functions of the back, and LBP disability 
treatments (15). The researcher also visited the 
workplace and home of each patient at baseline, 
weeks 4 and 8 of the GA interventions. The 
purposes of the work-place and home visits were to 
give the patient an opportunity to show his/her 
work and home situation, to enable the 
participant’s employment manager (if any) to 
become actively involved in the rehabilitation 
process. Participants in GAMWG had an 
objectively daily-monitored-walking programme 
besides GA. Participants were instructed to achieve 
the daily recommended level beneficial for health 
and wellbeing. This was based on the 5,500 daily 
steps recommendation for patients with chronic 
illness (16). Pedometer step counts were collected 
and used as an index to monitor adherence to the 
walking programme. 
Outcome measures: Primary outcome measures 
included Pain Intensity (PI) using a VAS, Static 
Back Extensor Muscles’ Endurance (SBEE), and 
Static Abdominal Muscular Endurance (SAME). A 
secondary measure of Glycaemic Control (GC) was 
assessed. The SBEE was assessed using 
the Biering-Sorensen test of static muscular 
endurance. It measured how long (to a maximum 
of 240 seconds) a participant could maintain the 
unsupported trunk (from the anterior iliac crests 
level up) horizontally while lying prone on a test 
bench (17). The flexor endurance test was used to 
assess the SAME of participants. Two strips of tape 
were placed parallel to each other and 3.5 inches 
(8.9 centimetres) apart. The participant lay supine 
on the mat with knees at right angles; the 
participant extended the arm so that the fingertips 
of both hands touched a strip of tape perpendicular 
to the body on both sides. The participant was 
asked to slide the fingertips on the mat until it 
reached the second set of tape strips. Then 
participant was to maintain this position for as long 
he or she could without moving their fingertips 
away from the second tape strip. The period of hold 
was noted with a stopwatch (17). A point-of-care 
system (In2it, Biorad Latvia) was used to assess 
participants’ HBA1c. Using Cohen’s table at 0.05 
α- level, 80% power and an effect size of 0.8 
(large), a group sample (n) = 20 was adopted for 
the study. The sample size (N) for the study was a 
minimum of 40 participants. 
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Data analysis: The data analyses were carried out 
using SPSS Statistics version 20.0 software (IBM 
Corp., Armonk, New York, USA). Descriptive 
statistical methods were used to describe the 
samples. Repeated measures analysis of variance 
(ANOVA) was used to determine within-group 
differences on PI, SAME and SBEE. Paired t-
test was used to compare the glycaemic control 
from baseline to week 12 for each GAG and 
GAMWG. Independent samples t-test was used to 
compare the mean change of primary outcomes and 
glycaemic control between the two groups. Effect 
sizes were calculated for the mean change of 
primary outcomes. For all analyses, level of 




Flow of participants: Fifty-eight consecutive 
patients (48.3±9.4 years, 65% females) with 
concomitant Low Back Pain (LBP) and Type 2 
Diabetes mellitus (T2DM) who met the inclusion 
criteria and agreed to participate in the study were 
randomized (29 per group) into GAG and 
GAMWG. The flow chart of recruitment is 


































Figure 1: Flowchart of participants’ recruitment and participation 
 
Socio-demographic and baseline characteristics 
of participants: The mean age, weight, height, 
BMI, duration of diagnosis of LBP and duration of 
the diagnosis of T2DM of all the participants were 
48.3±9.4 years, 68.8±5.8 Kg, 1.60±0.05 metres, 
26.9±4.0 Kg/m2, 17.3±18.6 months and 33.8±16.8 
months, respectively. The two groups were 
comparable in their baseline characteristics. The 
GAMWG (n = 29) 
3 Drop-outs (2 at Week 4, 1 
week 8). [Reason: Personal 
reasons: 1 and Relocation: 2 
 
4 drop-outs (at week 4). 
Reason: Distance from venue 
of exercise: 3 and persistent 
knee: pain: 1 
 
26 Analysed 
GAG (n = 29) 
25 Analysed 
Randomized (n= 58) 
58 participants (with concomitant 
LBP and T2DM) who met the 
inclusion criteria and were eligible to 
participate in the study 
 
Baseline assessment (n=58) 
Site 1 (n = 13) 
Site 2 (n = 38) 
Not recruited (n = 13)  
• Ineligible (n = 6) 
• Declined (n = 5) 
• Relocated (n = 2) 
Patients Screened (n = 71) 
Site 1 (n = 49) 
Site 2 (n =22) 
Site 2 (n = 38) 
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socio-demographic and baseline characteristics of 
the participants are presented in Table 1 and Table 
2.  
 
Table 1: Socio-demographic characteristics of all participants by treatment. 
 
Variable GAG (n=26) GAMWG (n=25) Total (n=51) 
Gender    
Male  10(38%) 8.0(32%) 18(35%) 
Female  16(62%) 17(68%) 33(65%) 
Marital status    
Married  25(96%) 24(96%) 49(96%) 
Widowed 1(4%) 1.0(4%) 2(4%) 
Education    
Pry School 0(0%) 6(24%)  6.0(12%) 
Sec. School 6.0(23%) 6(24%)  12(23%) 
Poly.  2.0(8%) 2(8%) 4.0(8%) 
University 18(69%) 11(44%) 29(57%) 
Occupational Status    
Unemployed 4(15%)  3(12%)  7.0(15%) 
Employed 18(70%) 17(68%) 35(68%) 
Retiree  4(15%)  5(20%) 9.0(17%) 
GAG - Graded Activity Group, GAMWG - Graded Activity with daily Monitored Walking Group, Pry - Primary 
Sec – Secondary, Poly - Polytechnic 
 
Table 2: Comparison of the participants’ baseline general characteristic by treatment groups 
 
Variable GAG (n=26) GAMWG (n=25)   
 Mean (SD) Mean (SD) t-value p-value 
Age (years) 48.27(9.56) 48.28(9.41) -0.00 0.99 
BMI (Kg/m2) 27.32(2.22) 26.48(3.62) 1.00 0.31 
Pain Intensity (cm)  6.95(0.10) 6.95(0.08) 0.22 0.83 
SAME (sec) 22.41(0.39) 22.48(0.27) -0.68 0.50 
SBEE (sec) 22.98(0.25) 23.02(0.24) -0.52 0.61 
Gly. Ctr. (%) 6.31(0.87) 6.33(0.90) 0.10 0.92 
GAG- Graded Activity Group, GAMWG - Graded Activity with daily Monitored Walking Group, SD - Standard 
Deviation, BMI - Body Mass Index, SAME - Static Abdominal Musculature Endurance, SBEE - Static Back Extensors 
Endurance, Gly. Ctr - Glycaemic Control 
 
Effects of intervention: There were differences 
in PI, SAME and SBEE across the four-time 
points of the study for participants in each of 
GAG and GAMWG (Table 3). Within-group 
analysis of glycaemic control was significant for 
GAMWG (6.3±0.9%, 5.7±0.6%; Effect size 
(ES)=1.16 (95% CI=0.65 to 1.67), p=0.00) but 
not GAG (6.3±0.8%, 6.3±0.9%; ES=0.21, 95% 
CI=-0.3 to 0.72), p=0.29) participants. Table 4 
shows the weeks 4, 8, and 12 comparisons of 
participants’ clinical outcome variable mean 
changes between participants in the GAG and 
GAMWG. Participants in the GAMWG had 
significantly higher mean change on SBEE scores 
than GAG scores at week 8 of the study. There 
was also a statistically significant difference in 
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the mean change glycaemic control between 
GAG and GAMWG participants (-0.05±0.2%, -
0.6±0.5%); ES=1.58; 95% CI=1.07 to 2.09, 
p=0.00) over the baseline through week 12 of the 
study.  
 
Table 3: Repeated measures ANOVA of participants’ clinical outcome variables of PI, SAME and SBEE in 
the GAG and GAMWG across the 4-time points of the study 
 
 
Table 4: Comparison of (mean change of) clinical outcome variables (PI, SAME and SBEE) between 
















GAG - Graded Activity Group, GAMWG - Graded Activity Protocol with daily Monitored Walking Group, SD   
- Standard Deviation, SAME - Static Abdominal Musculature Endurance, SBEE - Static Back Extensors Endurance, *- 







Variable Time Frame GAG (n=26) GAMWG (n=25) 
  Mean (SD) Mean (SD) 
PI (cm)  Week 0  6.95 (0.10)a 6.95 (0.08)a 
  Week 4 6.15 (0.09)b 6.11 (0.09)b 
 Week 8 4.43 (0.07)c  4.40 (0.07)c 
 Week 12 2.95 (0.09)d  2.87 (0.14)d 
F-value   20513.03 14360.79 
p-value   <0.001* <0.001* 
SAME (sec) Week 0  22.41(0.39)a 22.48 (0.27)a 
  Week 4  29.05 (0.34)b  29.13 (0.20)b 
  Week 8  36.06 (0.20)c 36.16 (0.11)c 
 Week 12  41.22 (0.17)d  41.35 (0.08)d  
 F-value   106331.45 157679.94 
p-value  <0.001* <0.001* 
SBEE (sec)  Week 0  22.98 (0.25)a 23.02 (0.24)a 
Week 4  25.35 (0.21)b 25.37 (0.21)b 
 Week 8  32.61 (0.19)c 32.71 (0.14)c 
 Week 12  37.11 (0.14)d 37.24 (0.13)d 
F-value   278142.60 93939.72 
p-value   <0.001* <0.001* 
Variable Time Frame GAG (n=26) GAMWG (n=25) Effect size (95% CI) p-value 
  Mean (SD) Mean (SD)   
PI (cm)  Week 4 -0.81(0.03) -0.83(0.06) 0.5(0.42 to 0.58) 0.08 
  Week 8 -1.71(0.06) -1.71(0.09) 0.04(-0.04, 0.12) 0.99 
 Week 12 -1.48(0.09) -1.53(0.12) 0.47(0.39 to 0.55) 0.09 
SAME (sec) Week 4   6.6(0.15) 6.6(0.09)   -0.06(-0.14 to 0.02)  0.83 
 Week 8  7.0(0.16) 7.0(0.10)  -0.95(-1.02 to 0.87) 0.58 
 Week 12 5.2(0.05) 5.2(0.0) 90.45(-0.53 to -0.37) 0.12 
SBEE (sec) Week 4   2.4(0.08) 2.4(0.10) 0.12(0.04 to 0.2) 0.67 
  Week 8  7.2(0.10) 7.3(0.10) -0.95(-1.02 to -0.87)            0.00* 
  Week 12 4.5(0.06) 4.5(0.08) 0.43(0.35 to 0.51) 0.13 
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Results from this study showed that graded activity 
(GA) reduced pain intensity among patients with 
concomitant low back pain (LBP) and Type 2 
Diabetes Mellitus (T2DM). Further GA 
significantly increased the static abdominal 
muscular endurance (SAME) and static back 
extensors endurance (SBEE) of participants across 
the time points of the study. The graded activity 
with daily monitored walking (GAMW) 
intervention had significant improvements in pain 
intensity (PI), SAME and SBEE of patients with 
concomitant LBP and T2DM. Compared to GA 
alone, GAMW led to more significant 
improvements on SBEE at week 8 and improved 
glycaemic control at the end of week 12.  
The reduction in pain intensity of patients with 
concomitant LBP and T2DM following GA in this 
study follows the same trend as reported by other 
studies from the general population (8,10-
11,18,20). For instance, Bello and colleagues found 
improvements in the PI of patients with chronic 
non-specific LBP after going through GA (11). 
However, in contrast to the present study, Steenstra 
et al. (21) reported that GA did not improve the 
back pain of workers. A major difference between 
the present study and that of Steenstra et al. was the 
extent to which the interventions were 
standardized. In this study, only I.O.A administered 
GA to the participants, and to a large extent could 
standardize the intervention. Steenstra and 
colleagues (21) referred patients to 16 facilities 
with about 47 physiotherapists and attempted to 
standardize their intervention. However, uniformity 
in interventions was unreachable (21). We attribute 
the positive effect of GA on the SAME and SBEE 
of patients with concomitant LBP and T2DM in 
this study to the effect of the treatment component 
of the GA. 
Our results are similar to those of previous 
studies which reported that GA increased the back 
muscle endurance of patients with LBP (19,20). 
 Lindstrom et al., however, reported a 
significant increase in the SAME but not SBEE of 
patients with LBP following GA (9). Our study and 
that of Roche and colleagues (19) reported only the 
short-term effect of GA on SBEE and SAME, 
Kankaanpa et al. (20) and Lindstrom et al. 
(9) however, had conflicting reports on the long-
term effects of GA on SBEE and SAME. While 
Kankaanpa et al (20) surmised that the increase in 
the SBEE and SAME following GA diminished on 
the long term, Lindstrom and colleagues reported 
that GA improved both SAME and SBEE 
significantly at 1-year follow-up. A major 
difference between the study of Lindstrom et 
al. and other studies, including this study, was the 
class of LBP being treated. Lindstrom et 
al. concentrated on patients with sub-acute LBP, 
others focussed on patients with chronic LBP. In 
addition, the present study further differs from 
previous studies because participants comprised 
patients with concomitant LBP and T2DM.  
Strengthening exercises aimed at the 
abdominal and back extensor muscles is 
premised on the known relationship between the 
weaknesses of these two muscle groups and LBP 
(22). Chronic LBP results in physical impairments, 
such as poor trunk and extremity muscle 
endurance, and alteration of muscle activation 
patterns (20). This results in lumbar instability and 
an increased risk of lumbar spine re-injury. Graded 
activity relieves back symptoms via the 
development of a sense of control over pain, 
elimination of pain avoidance, and improving 
overall physical fitness/function (11). When 
patients complete their exercises and discover that 
such exercises were not harmful to their back as 
they might have previously thought, they are likely 
to gain trust in the function of their back.  
Thus, they adjust their maladaptive pain 
beliefs, which ultimately lead to an improvement in 
physical functioning (11). Other suggested 
mechanisms through which exercises impact 
positively on LBP clinical outcomes include: 
modification of motor control patterns because of 
the weighting of sensory inputs, and possibly from 
a positive therapist-patient interaction or 
relationship (24). Thus, GA not only tackles pain 
and disability via the modification of mal-adaptive 
LBP behaviours but also corrects impairments such 
as reduced muscle strength and reduced endurance. 
Asides the fact that the components of the GA 
may have led to reduced pain and increased 
muscular endurance, additional daily-monitored-
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walking intervention may have further encouraged 
movement and an increase in PA despite the pain. 
This increase in the PA of the patients that received 
GAMW may have provided additional 
opportunities for healing in participants’ 
musculoskeletal systems. Physical activity 
facilitates healing in the musculoskeletal system by 
increasing peripheral circulation and nutrient 
supply to the back extensor musculature, 
mobilizing stiff joints, mechanically affecting disc 
pathology or a combination of all these different 
effects (25). As the primary aim of the GA is to get 
patients with LBP to be more physically active and 
be able to confront their fears about PA, daily 
monitored walking may provide additional PA 
opportunities. 
Compared to GA alone, GAMW led to a 
higher, more significant improvement on SBEE at 
week 8 and improved glycaemic control at the end 
of week 12. This result addresses the important 
research question whether the aerobic exercise in 
the treatment component of the GA is enough to 
manage patients with concomitant LBP and T2DM. 
It is adducible from the result that patients with 
concomitant LBP and T2DM will require an 
additional daily-monitored-walking home 
programmes which may not only address their LBP 
concerns but also improve their glycaemic control. 
Graded activity with monitored walking had 
significant positive effects on the glycaemic control 
of patients with concomitant LBP and T2DM than 
those who had GA alone. This might have led to 
improved general health status, increased exercise 
tolerance and increased PA. This may have resulted 
in reduced maladaptive and incongruent back pain 
behaviour, thus improving LBP outcomes among 
the participants who had GAMW. 
Alongside medication and diet, PA is 
important in attaining glucose control in patients 
with T2DM (25). There is accruing evidence that 
walking, a form of PA has beneficial effects on 
glycaemic control (26) and LBP (27). Walking is a 
moderate-intensity exercise with less risk of 
developing adverse cardiovascular or 
musculoskeletal injuries compared to more 
vigorous forms of exercise (28). Further, directly 
monitoring the PA of patients with LBP could 
serve as an adjunct to the main treatment regimen 
(29). Home-based walking programmes can 
be monitored through accelerometers and also by 
the use of pedometers. Pedometers are a better 
choice for the feedback of accumulated PA in 
clinical and real-life situations because it is 
relatively cheap and simple to understand (30). The 
pedometer can both serve as a feedback mechanism 
for PA activity (steps/day) accumulated by an 
individual and provide a benchmark for attainable 
PA. To enjoy the health benefits of walking as a 
form of PA, experts recommend 10,000 steps per 
day for the general population (16). Attaining this 
PA recommendation may however be impractical 
for T2DM, as these patients have to deal with 
myriad diabetic complications, 
including hyperglycaemia. Tudor-Locke and 
colleagues suggested that in individuals with 
chronic illnesses such as T2DM, it is more 
appropriate to work with gradual increases, based 
on the baseline number of steps (16).  
To the best of our knowledge, this is the first 
LBP intervention study conducted in a well-defined 
T2DM population. Further, this study is one of the 
very limited studies that assessed the effects of GA 
on back muscle endurance. 
This study is, however, not without 
limitations. It only assessed the short-term effect of 
GA; therefore, the results should be interpreted 
with caution. Second, the oral antidiabetic agents 
taken by some participants were not controlled for 
in this study. This, besides diet, could have in one 
way or the other influenced such individuals’ 
responses to exercise. Patients with chronic pain 
(LBP) often experience impairments in attention 
control, working memory, mental flexibility, 
problem-solving, and information processing 
speed. Further, pain experience may affect one’s 
personal judgments concerning such an 
individual’s ability to engage successfully in 
specific behaviours that lead to specific, desired 
outcomes. An exercise intervention such as the 
GA, which is quota-based and submaximal, may 
help to address these problems. Future studies 
should explore whether GA will be more effective 
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